NON-SMALL CELL CARCINOMA
Clinical trials for NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver zapping may boost immunotherapy in advanced lung cancer
Disease control Recruiting nowThis study tests whether adding a precise, high-dose radiation treatment to the liver (called L-SABR) to standard immunotherapy can help people with stage IV non-small cell lung cancer that has spread to the liver. About 68 adults will be randomly assigned to receive either stand…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 17, 2026 00:49 UTC
-
New hope for advanced lung cancer: experimental drug takes on chemo in major trial
Disease control Recruiting nowThis study compares a new experimental drug (PF-08046054) to standard chemotherapy (docetaxel) in about 680 adults with advanced PD-L1 positive non-small cell lung cancer that has worsened after prior treatments. Participants are randomly assigned to receive either the new drug o…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated May 17, 2026 00:45 UTC
-
New combo therapy aims to shrink tough lung tumors
Disease control Recruiting nowThis early-phase study tests whether adding an experimental drug called binimetinib to the immunotherapy pembrolizumab can help shrink tumors in people with advanced non-small cell lung cancer. About 40 participants with a specific type of lung cancer (PD-L1 high) will receive th…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
New pill targets Hard-to-Treat cancers with specific gene mutation
Disease control Recruiting nowThis early-phase study tests a new oral drug, DO-2, in adults with advanced solid tumors (like lung cancer) that have a specific MET gene change and no standard treatment options left. The main goal is to check the drug's safety and find the right dose. About 55 participants will…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: DeuterOncology • Aim: Disease control
Last updated May 04, 2026 16:17 UTC
-
Step up recovery: telecoaching aims to get lung cancer patients moving after surgery
Symptom relief Recruiting nowThis study tests a 12-week home-based coaching program for people who had surgery for early-stage lung cancer. Participants get a fitness tracker, a smartphone app, and coach calls to help them increase their daily steps. The goal is to see if this program improves physical activ…
Matched conditions: NON-SMALL CELL CARCINOMA
Phase: NA • Sponsor: University Hospital, Ghent • Aim: Symptom relief
Last updated May 11, 2026 20:47 UTC